These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30825248)

  • 61. Synthesis and anti-hepatitis B virus activity of novel benzimidazole derivatives.
    Li YF; Wang GF; He PL; Huang WG; Zhu FH; Gao HY; Tang W; Luo Y; Feng CL; Shi LP; Ren YD; Lu W; Zuo JP
    J Med Chem; 2006 Jul; 49(15):4790-4. PubMed ID: 16854087
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly Inhibitors.
    Zhang X; Cheng J; Ma J; Hu Z; Wu S; Hwang N; Kulp J; Du Y; Guo JT; Chang J
    ACS Infect Dis; 2019 May; 5(5):759-768. PubMed ID: 30525438
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phenylpropenamide derivatives: anti-hepatitis B virus activity of the Z isomer, SAR and the search for novel analogs.
    Wang P; Naduthambi D; Mosley RT; Niu C; Furman PA; Otto MJ; Sofia MJ
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4642-7. PubMed ID: 21704526
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibition of hepatitis B virus (HBV) replication by pyrimidines bearing an acyclic moiety: effect on wild-type and mutant HBV.
    Semaine W; Johar M; Tyrrell DL; Kumar R; Agrawal B
    J Med Chem; 2006 Mar; 49(6):2049-54. PubMed ID: 16539393
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro].
    Wu JM; Lin JS; Xie N; Qiu GF; Hu XM
    Yao Xue Xue Bao; 2005 Sep; 40(9):825-9. PubMed ID: 16342685
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.
    Delaney WE; Miller TG; Isom HC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2017-26. PubMed ID: 10428929
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A new antiviral scaffold for human norovirus identified with computer-aided approaches on the viral polymerase.
    Giancotti G; Rigo I; Pasqualetto G; Young MT; Neyts J; Rocha-Pereira J; Brancale A; Ferla S; Bassetto M
    Sci Rep; 2019 Dec; 9(1):18413. PubMed ID: 31804593
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation.
    Mani N; Cole AG; Phelps JR; Ardzinski A; Cobarrubias KD; Cuconati A; Dorsey BD; Evangelista E; Fan K; Guo F; Guo H; Guo JT; Harasym TO; Kadhim S; Kultgen SG; Lee ACH; Li AHL; Long Q; Majeski SA; Mao R; McClintock KD; Reid SP; Rijnbrand R; Snead NM; Micolochick Steuer HM; Stever K; Tang S; Wang X; Zhao Q; Sofia MJ
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555628
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis and biological evaluation of 1H-benzimidazol-5-ols as potent HBV inhibitors.
    Zhao Y; Liu Y; Chen D; Wei Z; Liu W; Gong P
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7230-3. PubMed ID: 21074429
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Design, synthesis and anti-HBV activity of NVR3-778 derivatives.
    Lv K; Wu S; Li W; Geng Y; Wu M; Zhou J; Li Y; Gao Q; Liu M
    Bioorg Chem; 2020 Jan; 94():103363. PubMed ID: 31669092
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Design, synthesis, and biological evaluation of new N(4)-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine derivatives as potent anti-HBV agents.
    Lv Z; He W; Tian X; Kang J; Liu Y; Peng Y; Zheng L; Wang Q; Yu W; Chang J
    Eur J Med Chem; 2015 Aug; 101():103-10. PubMed ID: 26119991
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The fight against the influenza A virus H1N1: synthesis, molecular modeling, and biological evaluation of benzofurazan derivatives as viral RNA polymerase inhibitors.
    Pagano M; Castagnolo D; Bernardini M; Fallacara AL; Laurenzana I; Deodato D; Kessler U; Pilger B; Stergiou L; Strunze S; Tintori C; Botta M
    ChemMedChem; 2014 Jan; 9(1):129-50. PubMed ID: 24285596
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthesis and Biological Evaluation of Matijin-Su Derivatives as Potential Antihepatitis B Virus and Anticancer Agents.
    Qiu J; Xu B; Gong Q; Pan W; Liu C; Huang Z; Gu X; Liang G
    Chem Biodivers; 2016 Nov; 13(11):1584-1592. PubMed ID: 27451105
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and biological assay of 4-aryl-6-chloro-quinoline derivatives as novel non-nucleoside anti-HBV agents.
    Guo RH; Zhang Q; Ma YB; Huang XY; Luo J; Wang LJ; Geng CA; Zhang XM; Zhou J; Jiang ZY; Chen JJ
    Bioorg Med Chem; 2011 Feb; 19(4):1400-8. PubMed ID: 21292495
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel ring-expanded nucleoside analogs exhibit potent and selective inhibition of hepatitis B virus replication in cultured human hepatoblastoma cells.
    Sood RK; Bhadti VS; Fattom AI; Naso RB; Korba BE; Kern ER; Chen HM; Hosmane RS
    Antiviral Res; 2002 Feb; 53(2):159-64. PubMed ID: 11750942
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antiviral therapy targeting viral polymerase.
    Tsai CH; Lee PY; Stollar V; Li ML
    Curr Pharm Des; 2006; 12(11):1339-55. PubMed ID: 16611119
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors.
    Zaher NH; Mostafa MI; Altaher AY
    Acta Pharm; 2020 Jun; 70(2):145-159. PubMed ID: 31955138
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors.
    Kim J; Kwon J; Lee D; Jo S; Park DS; Choi J; Park E; Hwang JY; Ko Y; Choi I; Ju MK; Ahn J; Kim J; Han SJ; Kim TH; Cechetto J; Nam J; Ahn S; Sommer P; Liuzzi M; No Z; Lee J
    Bioorg Med Chem Lett; 2013 Jan; 23(1):153-7. PubMed ID: 23206860
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis and quantitative structure-activity relationships study for phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.
    Yang J; Ma M; Wang XD; Jiang XJ; Zhang YY; Yang WQ; Li ZC; Wang XH; Yang B; Ma ML
    Eur J Med Chem; 2015 Jun; 99():82-91. PubMed ID: 26057705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.